Suppr超能文献

[原发性醛固酮增多症与肾上腺皮质腺瘤。地塞米松对醛固酮的抑制作用]

[Primary hyperaldosteronism and adenoma of the adrenal cortex. Suppression of aldosterone with dexamethasone].

作者信息

Bercovici J P, Roudaut N, Kerlan V, Aupetit-Faisant B, Floch H H

机构信息

CHU Brest Hôpital Cavale Blanche.

出版信息

Ann Endocrinol (Paris). 1998 Apr;59(1):20-2.

PMID:9752394
Abstract

The aim of the study was to evaluate dexamethazone test in a patient with primary aldosteronism caused by an adrenocortical adenoma. We observed a 50% decrease of plasma aldosterone as in glucocorticoid suppressible aldosteronism (GSA) but absolute value of aldosterone remained higher than 40 pg/ml. Basal plasma and urinary values of 18 OXO and 18 OH cortisol were not significantly elevated as in GSA. Inversely, the evaluation of 11 beta-hydroxylase activity of mineralocorticoids was in favor of a benign adrenal tumor.

摘要

本研究的目的是评估地塞米松试验在一名由肾上腺皮质腺瘤引起的原发性醛固酮增多症患者中的应用。我们观察到血浆醛固酮水平下降了50%,与糖皮质激素可抑制性醛固酮增多症(GSA)情况相同,但醛固酮的绝对值仍高于40 pg/ml。与GSA不同,18-氧代皮质醇和18-羟皮质醇的基础血浆和尿液值没有显著升高。相反,盐皮质激素11β-羟化酶活性的评估结果支持肾上腺良性肿瘤的诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验